MTOR and cancer: Downregulation of ERK1/2 and upregulation of the JNK pathways due to CP/PAL are usually accompanied with decreased PI3K/Akt/mTOR pathway and downstream NFκB activity in cancer cells to inhibit proliferation and promote caspase 9/3-dependent apoptosis [144,163,210].